What researchers think about the validity, and risk, of AI doomsday scenarios. Plus, a social network for agentic AI bots and how personalized CRISPR therapies could reach more people who need them. What researchers think about the validity, and risk, of AI doomsday scenarios. Plus, a social network for agentic AI bots and how personalized CRISPR therapies could reach more people who need them.
Flora Graham (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: